Introduction
Calcium Antagonists and Tissue Protection
Antiperoxidative Actions of Calcium Antagonists and Atherogenesis
Renal Protection with the Calcium Antagonists
The Future of Calcium Channel Blocker Therapy in Diabetes Mellitus
Treatment of Mild Hypertension
Metabolic Neutrality in Nitrendipine Therapy
Treatment of Isolated Systolic Hypertension in the Elderly
Panel Discussion
Nitrendipine Efficacy and Safety in Patients with Mild and Moderate Essential Hypertension
Low-Dose Nitrendipine in Mild Hypertension
Circadian Rhythm of Blood Pressure and Calcium Entry Blockade
Effectiveness of Nitrendipine, 20 mg Once Daily in the Management of Hypertension in General Practice
Antihypertensive Monotherapy with Nitrendipine in General Practice
A Comparative Study of the Effects of Nitrendipine and Enalapril in Essential Hypertension
A Double-Blind, Randomized, Comparative Study of Nitrendipine and Enalapril in Elderly Hypertensive Patients
Tolerance to Nitrendipine in Patients with Arterial Hypertension Accompanying Chronic Renal Failure
Arteriosclerosis and Antihypertensive Response to Calcium Antagonists in End-Stage Renal Failure
Cardiovascular Side Effects After Renal Allograft Rejection Therapy with Orthoclone
Influence of the Calcium Antagonist Nitrendipine on the Hepatotoxic Effect of Cyclosporine A
Long-Term (3 Years) Sustained Antihypertensive and Metabolic Actions of Nitrendipine in Severe, Complicated, and Resistant Hypertension
Effects of Nifedipine and Nitrendipine on Insulin Secretion in Obese Patients
Nitrendipine Once or Twice Daily in Hypertensive Non-Insulin-Dependent Diabetes Mellitus
Effect of Nitrendipine in Mild or Moderate Essential Hypertensive Subjects with Type II Diabetes
Nitrendipine and Atenolol in Essential Hypertension in Young and Middle-Aged Patients
Influence of Therapy on Silent Ischemia and Ventricular Arrhythmias in Hypertensive Patients
Cerebral Blood Flow Is Not Altered by Treatment with Nitrendipine in Patients with Mild to Moderate Hypertension
Closing Remarks